| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Rafael Holdings, Inc. | Chief Executive Officer | Class B Common Stock, par value $.01 per share | 564,455 | $1,055,643 | $1.87 | 25 Mar 2025 | Direct |
| Rafael Holdings, Inc. | Chief Executive Officer | Class B Common Stock, par value $.01 per share | 520,749 | $757,690 | $1.46 | 21 Jun 2024 | Direct |
| Protara Therapeutics, Inc. | Chief Commercial Officer | Common Stock | 50,000 | $179,000 | $3.58 | 02 Jun 2025 | Direct |
| Cyclo Therapeutics, Inc. | Director | Common Stock | 77,884 | $49,067 | $0.6300 | 27 Feb 2025 | Direct |
| Protara Therapeutics, Inc. | Chief Commercial Officer | Stock Option (Right to Buy) | 200,000 | 02 Jun 2025 | Direct | ||
| Cyclo Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 15,562 | 03 Jun 2024 | Direct | ||
| Rafael Holdings, Inc. | Chief Executive Officer | Employee Stock Option (right to buy) | 5,485 | 25 Mar 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| TARA | Protara Therapeutics, Inc. | 02 Jun 2025 | 2 | $0 | 4 | Chief Commercial Officer | 04 Jun 2025, 16:10 |
| TARA | Protara Therapeutics, Inc. | 02 Jun 2025 | 0 | $0 | 3 | Chief Commercial Officer | 04 Jun 2025, 16:05 |
| RFL | Rafael Holdings, Inc. | 25 Mar 2025 | 3 | $0 | 4 | Chief Executive Officer | 24 Apr 2025, 15:18 |
| RFL | Rafael Holdings, Inc. | 21 Mar 2025 | 1 | -$28,591 | 4 | Chief Executive Officer | 25 Mar 2025, 16:39 |
| CYTH | Cyclo Therapeutics, Inc. | 27 Feb 2025 | 1 | $0 | 4 | Director | 03 Mar 2025, 11:45 |
| RFL | Rafael Holdings, Inc. | 13 Jan 2025 | 1 | +$117,240 | 4 | Chief Executive Officer | 15 Jan 2025, 14:22 |
| RFL | Rafael Holdings, Inc. | 21 Dec 2024 | 1 | -$23,501 | 4 | Chief Executive Officer | 23 Dec 2024, 15:27 |
| CYTH | Cyclo Therapeutics, Inc. | 15 Nov 2024 | 1 | $0 | 4 | Director | 18 Nov 2024, 14:11 |
| RFL | Rafael Holdings, Inc. | 25 Oct 2024 | 1 | -$6,313 | 4 | Chief Executive Officer | 29 Oct 2024, 17:15 |
| RFL | Rafael Holdings, Inc. | 21 Sep 2024 | 1 | -$21,901 | 4 | Chief Executive Officer | 24 Sep 2024, 13:03 |
| CYTH | Cyclo Therapeutics, Inc. | 16 Aug 2024 | 1 | $0 | 4 | Director | 20 Aug 2024, 13:49 |
| RFL | Rafael Holdings, Inc. | 21 Jun 2024 | 1 | -$19,344 | 4 | Chief Executive Officer | 25 Jun 2024, 14:50 |
| CYTH | Cyclo Therapeutics, Inc. | 03 Jun 2024 | 2 | $0 | 4 | Director | 05 Jun 2024, 17:07 |
| RFL | Rafael Holdings, Inc. | 21 Mar 2024 | 1 | +$26,381 | 4 | Chief Executive Officer | 25 Mar 2024, 09:40 |
| CYTH | Cyclo Therapeutics, Inc. | 13 Feb 2024 | 1 | $0 | 4 | Director | 15 Feb 2024, 16:41 |
| RFL | Rafael Holdings, Inc. | 21 Dec 2023 | 1 | +$24,756 | 4 | Chief Executive Officer | 26 Dec 2023, 14:23 |
| CYTH | Cyclo Therapeutics, Inc. | 28 Nov 2023 | 1 | $0 | 4 | Director | 30 Nov 2023, 09:08 |
| RFL | Rafael Holdings, Inc. | 25 Oct 2023 | 1 | +$60,600 | 4 | Chief Executive Officer | 26 Oct 2023, 16:10 |
| RFL | Rafael Holdings, Inc. | 21 Sep 2023 | 1 | -$30,140 | 4 | Chief Executive Officer | 22 Sep 2023, 09:10 |
| CYTH | Cyclo Therapeutics, Inc. | 18 Aug 2023 | 1 | $0 | 4 | Director | 22 Aug 2023, 16:07 |
| RFL | Rafael Holdings, Inc. | 21 Jun 2023 | 1 | -$32,616 | 4 | Chief Executive Officer | 22 Jun 2023, 13:21 |
| CYTH | Cyclo Therapeutics, Inc. | 06 Jun 2023 | 1 | $0 | 4 | Director | 07 Jun 2023, 20:46 |
| CYTH | Cyclo Therapeutics, Inc. | 02 May 2023 | 0 | $0 | 3 | Director | 08 May 2023, 16:02 |
| RFL | Rafael Holdings, Inc. | 21 Mar 2023 | 1 | -$26,094 | 4 | Chief Executive Officer | 23 Mar 2023, 09:26 |
| RFL | Rafael Holdings, Inc. | 21 Dec 2022 | 1 | -$98,822 | 4 | Chief Executive Officer | 23 Dec 2022, 09:02 |
| RFL | Rafael Holdings, Inc. | 01 Feb 2022 | 1 | $0 | 4 | Chief Executive Officer | 03 Feb 2022, 07:48 |